Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
51%

OVERLAP
BY WEIGHT
10

# OF OVERLAPPING
HOLDINGS
MEDX
28
HOLDINGS
36%
ALSO IN PPH
PPH
26
HOLDINGS
43%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus PPH)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in PPH
Overlap
ELI LILLY & CO 13.9% 16.7% 13.9%
NOVARTIS AG-ADR 7.1% 7.9% 7.1%
JOHNSON & JOHNSON 5.0% 11.6% 5.0%
ABBVIE INC 9.4% 5.0% 5.0%
ASTRAZENECA PLC-SPONS ADR 5.4% 5.0% 5.0%
MEDX Overweight Relative to PPH
ALNYLAM PHARMACEUTICALS INC 6.6%
ABBVIE INC 4.4%
AMGEN INC 4.0%
ALKERMES PLC 4.0%
CRISPR THERAPEUTICS AG 3.3%
IONIS PHARMACEUTICALS, INC. 3.1%
BIOGEN IDEC INC 2.5%
REGENERON PHARMACEUTICALS 2.5%
GALECTIN THERAPEUTICS INC 1.3%
BEAM THERAPEUTICS, INC. 0.9%
MEDX Underweight Relative to PPH
JOHNSON & JOHNSON -6.6%
NOVO-NORDISK A/S-SPONS ADR -6.1%
SANOFI-AVENTIS-ADR -4.7%
MCKESSON CORP -4.4%
ZOETIS INC -4.3%
CENCORA INC -3.7%
TAKEDA PHARMACEUTICAL CO. LTD. SPONS -2.9%
MERCK & CO. INC. -2.9%
ELI LILLY & CO -2.7%
GLAXOSMITHKLINE PLC-SPON ADR -1.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY